You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大行評級|建銀國際:上調藥明康德目標價至82港元 強勁訂單積壓支持更樂觀前景
格隆匯 03-19 14:08
建銀國際發表研究報告指,藥明康德去年第四季收入及毛利率均勝於預期。考慮到公司去年訂單積壓量按年增加47%,該行認爲今年訂單積壓量仍然強勁,料今年首季將保持相若的增長水平;第四季營運利潤率爲29.4%,高於預期。該行指,藥明康德第四季純利28.4億元,高於預期,主要是毛利率出現滲漏效應。藥明康德宣佈派特別股息35分,以及回購10億元A股來回饋股東。該行指,將藥明康德在2025年至2032年銷售及毛利率預測分別上調9.9%及1.9個百分點,同時將其目標價由63港元上調至82港元,維持其評級爲“跑贏大市”。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account